Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors

Bioorg Med Chem Lett. 2019 Jan 1;29(1):119-123. doi: 10.1016/j.bmcl.2018.10.018. Epub 2018 Oct 12.

Abstract

Herein we report a study of novel arylchromene derivatives as analogs of naturally occurring flavonoids with prominent α-glucosidase inhibitory properties. Novel inhibitors were identified via simple stepwise in silico screening, efficient synthesis, and biological evaluation. It is shown that 2-aryl-4H-chromene core retains pharmacophore properties while being readily available synthetically. A lead compound identified through screening inhibits yeast α-glucosidase with IC50 of 62.26 µM and prevents postprandial hyperglycemia in rats at 2.2 mg/kg dose.

Keywords: Chromene; Diabetes mellitus; Flavonoids; α-Glucosidase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Benzopyrans / administration & dosage
  • Benzopyrans / chemistry
  • Benzopyrans / pharmacology*
  • Dose-Response Relationship, Drug
  • Glycoside Hydrolase Inhibitors / administration & dosage
  • Glycoside Hydrolase Inhibitors / chemistry
  • Glycoside Hydrolase Inhibitors / pharmacology*
  • Male
  • Models, Molecular
  • Molecular Structure
  • Rats
  • Rats, Wistar
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / enzymology
  • Structure-Activity Relationship
  • alpha-Glucosidases / metabolism*

Substances

  • Benzopyrans
  • Glycoside Hydrolase Inhibitors
  • alpha-Glucosidases